speb/financial-data huggingface dataset:
CVVY.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 438417000.00
CVVY.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 491955000.00
CVVY.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 322685000.00
CVVY.TO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 1538000.00
CVVY.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 20410000.00
CVVY.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 20410000.00
CVVY.TO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 1268000.00
CVVY.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: -36217000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 53533000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 59585000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 70484000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 37158000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -323177000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 13793000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 290401488.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
CVVY.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 11408000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2391000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4485000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 306304000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6567000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6567000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1446000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -4994000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1599000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -12634000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -4841000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 306304000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 159346000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 18734000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 89099000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1628000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 17572000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 19200000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 100063000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 6428000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 1017000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 1017000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 14257000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 290541726.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
CVVY.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — EBIT: 10042000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — EBITDA: 24299000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 6567000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 11225000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1446000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -792000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 789000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 24078000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 39112000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 7535000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 690125000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 40851000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 35090000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 4878000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4878000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 4744000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 3669000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 306080000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -4994000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 4163000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2857000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 129162000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 132019000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 4163000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -5621000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 159923000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 140167000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -8256000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Income: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 4147000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 4147000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -6232000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1458000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1458000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -6232000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -2603000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 366948000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2391000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 159346000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 85944000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 85944000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 221000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -15189070.10
CVVY.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1599000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -7467000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Operating Income: -12682000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 59449000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 290419642.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 6615000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 17572000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 3951000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 39112000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1349000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 5916000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 24078000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2217000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 45998000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 690125000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Payables: 70484000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 70484000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 5164000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 12000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2391000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 37158000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 18734000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 14257000.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -5621000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -201212000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1619000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7535000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 290419642.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CVVY.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 62000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 159346000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 159346000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 4741929.90
CVVY.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 1017000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 553216000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 288508000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 151219000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 159346000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 72267000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 393870000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 464117000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 293807000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 1354000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 24078000.00
CVVY.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 24078000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 1865000.00
CVVY.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -10964000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 54299000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 46705000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 63861000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 36980000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -336215000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 13856000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 290492000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.03
CVVY.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6566000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4022000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 4585000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 306443000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10192000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10192000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1641000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2481000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 4466000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -7303000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 3626000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 306443000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 137948000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 14825000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 83487000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1726000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 9856000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 11582000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 90819000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 5298000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -1346000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -1346000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 13606000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 290492000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.03
CVVY.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — EBIT: -6427000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — EBITDA: 7179000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 10192000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets: 4845000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1641000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 444000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 6062000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 17210000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 27598000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 12371000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 693409000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 31880000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 26563000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 5005000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5005000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Interest Income: 28000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 28000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 4867000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 3694000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 291014000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2481000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 12430000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2859000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 143210000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 146069000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 12430000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -10778000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 159961000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 142874000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 3068000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Income: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -10086000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -10086000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -6223000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 1652000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 1652000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6223000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -150000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 1541000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 357194000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -4022000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 137948000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 90748000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 90748000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -10031000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -25269700.14
CVVY.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 4466000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 9130000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Operating Income: -22419000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 45696000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 290616070.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 6058000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 9856000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 10078000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 27598000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1349000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 5557000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 17210000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 402000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 41928000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 693409000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Payables: 63861000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 63861000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -11432000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 139000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -4022000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 36980000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 14825000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 13606000.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -10778000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -211298000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 6814000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 12371000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 290616070.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CVVY.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 63000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 137948000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 137948000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 2026299.86
CVVY.TO income_statement (quarterly, 2025-09-30) — Tax Provision: -1346000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.12
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 536274000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 281158000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 157651000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 137948000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 69124000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 398326000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 452787000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 307507000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 1246000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 17210000.00
CVVY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 17210000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 1477000.00
CVVY.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -7332000.00
CVVY.TO income_statement (annual, 2025-12-31) — +Operating Expense: 222160000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 58054000.00
CVVY.TO income_statement (annual, 2025-12-31) — +Total Revenue: 228156000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 62316000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 77520000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 77520000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 45830000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 45830000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -346056000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -346056000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 13922000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 13922000.00
CVVY.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 290482104.00
CVVY.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.02
CVVY.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8576000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 10192000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -23359000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -10404000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 4499000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4499000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 307182000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 307182000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5799000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5799000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5799000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5799000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 5799000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5799000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -16840000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1266000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -22390000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -10903000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 36453000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7776000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -18741000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 23000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -2777000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4393000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Common Stock: 307182000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 307182000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 138547000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 138547000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CVVY.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 51298000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 5443000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Current Assets: 86524000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 86524000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1826000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1826000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Current Debt: 9704000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 9704000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 11530000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11530000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 109827000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 109827000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 7900000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 7900000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 7199000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 6025000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 7199000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 6025000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Depreciation: 41057000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 41057000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 365000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 41057000.00
CVVY.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 290482104.00
CVVY.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
CVVY.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — EBIT: 22834000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — EBIT: 9367000.00
CVVY.TO income_statement (annual, 2025-12-31) — EBITDA: 63891000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — EBITDA: 9732000.00
CVVY.TO cash_flow (annual, 2025-12-31) — End Cash Position: 5799000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 5799000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 8162000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 8162000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -16840000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1266000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 13094000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2628000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 10624000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 2864000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
CVVY.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CVVY.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 73476000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 11778000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 28990000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 28990000.00
CVVY.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 35669000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 8744000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 705481000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 705481000.00
CVVY.TO income_statement (annual, 2025-12-31) — Gross Profit: 176858000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 56873000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 24990000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 24990000.00
CVVY.TO income_statement (annual, 2025-12-31) — Interest Expense: 20506000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 4940000.00
CVVY.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 20506000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4940000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 18385000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 4799000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Inventory: 3783000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 3783000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 289395000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 289395000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -22390000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -10903000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CVVY.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 19383000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2790000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2673000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2673000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 141144000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 141144000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 143817000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 143817000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 19383000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2790000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -36171000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -4017000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 144319000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 144319000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 14000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Net Debt: 145049000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 145049000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -7838000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -2456000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Income: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Income: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1598000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -4871000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -4871000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1598000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Interest Income: -25846000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -6170000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -16788000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1227000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -16788000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -1227000.00
CVVY.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -25846000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6170000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 969000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -499000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Net PPE: 359425000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 359425000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -23359000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -10404000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 138547000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 138547000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 85025000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 85025000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 85025000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 85025000.00
CVVY.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -9585000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2046000.00
CVVY.TO income_statement (annual, 2025-12-31) — Normalized Income: -67325600.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -11609300.00
CVVY.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 36453000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 7776000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 2786000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 408000.00
CVVY.TO income_statement (annual, 2025-12-31) — Operating Income: -45302000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Operating Income: -1181000.00
CVVY.TO income_statement (annual, 2025-12-31) — Operating Revenue: 226739000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 62137000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 290680270.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 290680270.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 6122000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6122000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 9704000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 9704000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 12877000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 12877000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 28990000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 28990000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1349000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1349000.00
CVVY.TO income_statement (annual, 2025-12-31) — Other Gand A: 22743000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 5694000.00
CVVY.TO income_statement (annual, 2025-12-31) — Other Income Expense: 73476000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 11778000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1889000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -4360000.00
CVVY.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 186491000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 49310000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Other Properties: 705481000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 705481000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Payables: 77520000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Payables: 77520000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 77520000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 77520000.00
CVVY.TO income_statement (annual, 2025-12-31) — Pretax Income: 2328000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 4427000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -52000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -203000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -23359000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -10404000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Receivables: 45830000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 45830000.00
CVVY.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 51298000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5443000.00
CVVY.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 41057000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 365000.00
CVVY.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -36171000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -4017000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -212896000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -212896000.00
CVVY.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 12926000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 3050000.00
CVVY.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 35669000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 8744000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Share Issued: 290680270.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 290680270.00
CVVY.TO income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CVVY.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 7134000.00
CVVY.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6913000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 138547000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 138547000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 138547000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 138547000.00
CVVY.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 11021400.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 1766700.00
CVVY.TO income_statement (annual, 2025-12-31) — Tax Provision: 7199000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 6025000.00
CVVY.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
CVVY.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Assets: 539136000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 539136000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 279691000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 279691000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Debt: 155347000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 155347000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 138547000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 138547000.00
CVVY.TO income_statement (annual, 2025-12-31) — Total Expenses: 273458000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 63497000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 400589000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 400589000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 452612000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 452612000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 290762000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 290762000.00
CVVY.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 5340000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 1230000.00
CVVY.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 73476000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 11778000.00
CVVY.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 73476000.00
CVVY.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 11778000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 2626000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 2626000.00
CVVY.TO balance_sheet (annual, 2025-12-31) — Working Capital: -23303000.00
CVVY.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -23303000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 66131000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 86524000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 82534000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 41008000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -345373000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 13963000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 291635598.00
CVVY.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.01
CVVY.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5799000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6304000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 4281000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 329482000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9500000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9500000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 9500000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -34121000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -7590000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 45412000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 20044000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 20044000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3701000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 329482000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 154304000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 9614000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 83789000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1742000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 74176000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 75918000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 13886000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 13886000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 173438000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1100000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 3300000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 3300000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 9614000.00
CVVY.TO balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 1380000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 294210742.00
CVVY.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.01
CVVY.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3538000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — EBIT: 10922000.00
CVVY.TO income_statement (quarterly, 2026-03-31) — EBITDA: 20536000.00
CVVY.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 9500000.00